Upregulating sirtuin 6 ameliorates glycolysis, EMT and distant metastasis of pancreatic adenocarcinoma with krüppel-like factor 10 deficiency
Yi-Chih Tsai, Su-Liang Chen, Shu-Ling Peng, Ya-Li Tsai, Zuong-Ming Chang, Vincent Hung-Shu Chang, Hui-Ju Ch'ang, Yi-Chih Tsai, Su-Liang Chen, Shu-Ling Peng, Ya-Li Tsai, Zuong-Ming Chang, Vincent Hung-Shu Chang, Hui-Ju Ch'ang
Abstract
Krüppel-like factor 10 (KLF10) is a tumor suppressor in multiple cancers. In a murine model of spontaneous pancreatic adenocarcinoma (PDAC), additional KLF10 depletion accelerated distant metastasis. However, Klf10 knockout mice, which suffer from metabolic disorders, do not develop malignancy. The mechanisms of KLF10 in PDAC progression deserve further exploration. KLF10-depleted and KLF10-overexpressing PDAC cells were established to measure epithelial-mesenchymal transition (EMT), glycolysis, and migration ability. A murine model was established to evaluate the benefit of genetic or pharmacological manipulation in KLF10-depleted PDAC cells (PDACshKLF10). Correlations of KLF10 deficiency with rapid metastasis, elevated EMT, and glycolysis were demonstrated in resected PDAC tissues, in vitro assays, and murine models. We identified sirtuin 6 (SIRT6) as an essential mediator of KLF10 that modulates EMT and glucose homeostasis. Overexpressing SIRT6 reversed the migratory and glycolytic phenotypes of PDACshKLF10 cells. Linoleic acid, a polyunsaturated essential fatty acid, upregulated SIRT6 and prolonged the survival of mice injected with PDACshKLF10. Modulating HIF1α and NFκB revealed that EMT and glycolysis in PDAC cells were coordinately regulated upstream by KLF10/SIRT6 signaling. Our study demonstrated a novel KLF10/SIRT6 pathway that modulated EMT and glycolysis coordinately via NFκB and HIF1α. Activation of KLF10/SIRT6 signaling ameliorated the distant progression of PDAC.Clinical Trial Registration: ClinicalTrials.gov. identifier: NCT01666184.
Conflict of interest statement
The authors declare no competing interests.
© 2021. The Author(s).
Figures
References
- Ahmed S, Bradshaw AD, Gera S, Dewan MZ, Xu R. The TGF-beta/Smad4 signaling pathway in pancreatic carcinogenesis and Its clinical significance. J. Clin. Med. 2017;6:5–16. doi: 10.3390/jcm6010005.
- Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer. 2010;10:415–424. doi: 10.1038/nrc2853.
- Subramaniam M, Hawse JR, Rajamannan NM, Ingle JN, Spelsberg TC. Functional role of KLF10 in multiple disease processes. Biofactors. 2010;36:8–18.
- Memon A, Lee WK. KLF10 as a tumor suppressor gene and Its TGF-beta signaling. Cancers (Basel) 2018;10:161–179. doi: 10.3390/cancers10060161.
- Chang VH, et al. Kruppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma. Am. J. Pathol. 2012;181:423–430. doi: 10.1016/j.ajpath.2012.04.025.
- Weng CC, et al. KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the Kras(G12D) p53(flox/flox) model. Oncogene. 2017;36:5532–5543. doi: 10.1038/onc.2017.155.
- Mishra VK, et al. Kruppel-like transcription factor KLF10 suppresses TGFbeta-induced epithelial-to-mesenchymal transition via a negative feedback mechanism. Cancer Res. 2017;77:2387–2400. doi: 10.1158/0008-5472.CAN-16-2589.
- Guillaumond F, et al. Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver. Mol. Cell. Biol. 2010;30:3059–3070. doi: 10.1128/MCB.01141-09.
- Iizuka K, Takeda J, Horikawa Y. Kruppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes. Biochem. Biophys. Res. Commun. 2011;412:638–643. doi: 10.1016/j.bbrc.2011.08.016.
- Hsu CF, et al. Klf10 induces cell apoptosis through modulation of BI-1 expression and Ca2+ homeostasis in estrogen-responding adenocarcinoma cells. Int. J. Biochem. Cell Biol. 2011;43:666–673. doi: 10.1016/j.biocel.2011.01.010.
- Chang AR, Ferrer CM, Mostoslavsky R. SIRT6, a mammalian deacylase with multitasking abilities. Physiol. Rev. 2020;100:145–169. doi: 10.1152/physrev.00030.2018.
- Feldman JL, Baeza J, Denu JM. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 2013;288:31350–31356. doi: 10.1074/jbc.C113.511261.
- Lilja J, et al. SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. Nat. Cell Biol. 2017;19:292–305. doi: 10.1038/ncb3487.
- Rahman A, et al. Vinculin regulates directionality and cell polarity in 2D, 3D matrix and 3D microtrack migration. Mol. Biol. Cell. 2016;27:1431–1441. doi: 10.1091/mbc.E15-06-0432.
- van Gisbergen MW, et al. Distinct radiation responses after in vitro mtDNA depletion are potentially related to oxidative stress. PLoS One. 2017;12:1–13 e0182508.
- Nicholls DG, et al. Bioenergetic profile experiment using C2C12 myoblast cells. J. Vis. Exp. 2010;46:e2511.
- Yang DH, et al. Kruppel-like factor 10 upregulates the expression of cyclooxygenase 1 and further modulates angiogenesis in endothelial cell and platelet aggregation in gene-deficient mice. Int. J. Biochem. Cell Biol. 2013;45:419–428. doi: 10.1016/j.biocel.2012.11.007.
- Hwang YC, et al. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association. Biochim. Biophys. Acta. 2013;1833:3035–3045. doi: 10.1016/j.bbamcr.2013.08.010.
- Soares KC, et al. A preclinical murine model of hepatic metastases. J. Vis. Exp. 2014;91:51677–51687.
- Wu MJ, et al. KLF10 affects pancreatic function via the SEI-1/p21Cip1 pathway. Int. J. Biochem. Cell Biol. 2015;60:53–59. doi: 10.1016/j.biocel.2014.12.021.
- Smith W, Mukhopadhyay R. Essential fatty acids: the work of George and Mildred Burr. J. Biol. Chem. 2012;287:35439–35441. doi: 10.1074/jbc.O112.000005.
- Michishita E, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452:492–496. doi: 10.1038/nature06736.
- Zhong L, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell. 2010;140:280–293. doi: 10.1016/j.cell.2009.12.041.
- Zhang Y, et al. Drug-induced regeneration in adult mice. Sci. Transl. Med. 2015;7:290–292.
- Chang VH, et al. Krupple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene. Radiother. Oncol. 2017;122:476–484. doi: 10.1016/j.radonc.2017.01.001.
- Tetreault MP, Yang Y, Katz JP. Kruppel-like factors in cancer. Nat. Rev. Cancer. 2013;13:701–713. doi: 10.1038/nrc3582.
- Pollak NM, Hoffman M, Goldberg IJ, Drosatos K. Kruppel-like factors: crippling and un-crippling metabolic pathways. JACC Basic. Transl. Sci. 2018;3:132–156. doi: 10.1016/j.jacbts.2017.09.001.
- Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003;4:206. doi: 10.1186/gb-2003-4-2-206.
- Ellenrieder V, Zhang JS, Kaczynski J, Urrutia R. Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor. EMBO J. 2002;21:2451–2460. doi: 10.1093/emboj/21.10.2451.
- Sebastian C, et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell. 2012;151:1185–1199. doi: 10.1016/j.cell.2012.10.047.
- Han Z, Liu L, Liu Y, Li S. Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 2014;7:4774–4781.
- Tian K, et al. Sirtuin 6 inhibits epithelial to mesenchymal transition during idiopathic pulmonary fibrosis via inactivating TGF-beta1/Smad3 signaling. Oncotarget. 2017;8:61011–61024. doi: 10.18632/oncotarget.17723.
- Li Z, et al. SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4. J. Exp. Clin. Cancer Res. 2018;37:323–334. doi: 10.1186/s13046-018-0984-z.
- Yang Z, Yu W, Huang R, Ye M, Min Z. SIRT6/HIF-1alpha axis promotes papillary thyroid cancer progression by inducing epithelial-mesenchymal transition. Cancer Cell Int. 2019;19:17–30. doi: 10.1186/s12935-019-0730-4.
- Han LL, Jia L, Wu F, Huang C. Sirtuin6 (SIRT6) promotes the EMT of hepatocellular carcinoma by stimulating autophagic degradation of E-cadherin. Mol. Cancer Res. 2019;17:2267–2280. doi: 10.1158/1541-7786.MCR-19-0321.
- Carafa V, Altucci L, Nebbioso A. Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype. Front. Pharmacol. 2019;10:1–14. doi: 10.3389/fphar.2019.00038.
- Bhattacharya D, Scime A. Metabolic regulation of epithelial to mesenchymal transition: implications for endocrine. Cancer Front. Endocrinol. (Lausanne) 2019;10:773. doi: 10.3389/fendo.2019.00773.
- Li L, Li W. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharmacol. Ther. 2015;150:33–46. doi: 10.1016/j.pharmthera.2015.01.004.
- Carreno M, et al. Nitro-fatty acids as activators of hSIRT6 deacetylase activity. J. Biol. Chem. 2020;295:18355–18366. doi: 10.1074/jbc.RA120.014883.
- Kanfi Y, et al. Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett. 2008;582:543–548. doi: 10.1016/j.febslet.2008.01.019.
- Hamel FG. Preliminary report: inhibition of cellular proteasome activity by free fatty acids. Metabolism. 2009;58:1047–1049. doi: 10.1016/j.metabol.2009.04.005.
- Van Meter M, Mao Z, Gorbunova V, Seluanov A. SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle. 2011;10:3153–3158. doi: 10.4161/cc.10.18.17435.
- Vaughan RA, Garcia-Smith R, Bisoffi M, Conn CA, Trujillo KA. Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells. Lipids Health Dis. 2012;11:142–152. doi: 10.1186/1476-511X-11-142.
- Zock PL, Katan MB. Linoleic acid intake and cancer risk: a review and meta-analysis. Am. J. Clin. Nutr. 1998;68:142–153. doi: 10.1093/ajcn/68.1.142.
- Zhou Y, Wang T, Zhai S, Li W, Meng Q. Linoleic acid and breast cancer risk: a meta-analysis. Public Health Nutr. 2016;19:1457–1463. doi: 10.1017/S136898001500289X.
- Kawahara TL, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell. 2009;136:62–74. doi: 10.1016/j.cell.2008.10.052.
Source: PubMed